MOTS-C
Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-C is a 16-amino acid mitochondrial-derived peptide (MDP) encoded by mitochondrial DNA. It plays a crucial role in regulating metabolic homeostasis, glucose metabolism, and insulin sensitivity. MOTS-C has shown promising therapeutic potential in aging, diabetes management, cardiovascular health, and physical performance enhancement. Currently in research phase with no clinical approval.
How MOTS-C Works
From Injection to Results
The Injection
You inject MOTS-C under your skin (subcutaneous). The mitochondrial-derived peptide begins absorbing into your bloodstream through local capillaries.
Cellular Uptake & AMPK Activation
MOTS-C enters cells and activates AMP-activated protein kinase (AMPK) pathways, the body's master energy sensor that regulates cellular metabolism.
Mitochondrial Enhancement
AMPK activation triggers mitochondrial biogenesis and improves existing mitochondrial function, enhancing cellular energy production and efficiency.
Metabolic Optimization
Enhanced glucose metabolism and insulin sensitivity occur as MOTS-C modulates the folate/methionine cycle and optimizes cellular energy balance.
Cumulative Longevity Effects
Sustained use may lead to improved age-related markers, enhanced physical performance, better glucose control, and increased cellular stress resistance.
The Science Behind It
In Plain Terms
Think of MOTS-C as your body's cellular energy manager. It works like a smart thermostat that helps your cells produce and use energy more efficiently. When your mitochondria (the cell's power plants) start to decline with age, MOTS-C acts as a repair signal that tells your cells to make more energy and work better. It's like having a maintenance crew that keeps your cellular machinery running smoothly and efficiently.
Technical Details
MOTS-C functions as a mitochondrial-nuclear communication peptide that activates AMP-activated protein kinase (AMPK) signaling pathways. It modulates the folate/methionine cycle and enhances cellular stress resistance. MOTS-C interacts with nuclear genes to regulate metabolic homeostasis, particularly glucose metabolism and insulin sensitivity. The peptide promotes mitochondrial biogenesis, improves oxidative metabolism, and provides cytoprotection against age-related cellular damage.
Medical Disclaimer
MOTS-C is an experimental peptide not approved by the FDA for therapeutic use. It is banned by WADA for athletic competition. All information is for educational purposes only and should not constitute medical advice. Consult healthcare professionals before considering any peptide therapy. Long-term safety and efficacy in humans remain unknown.